Guidance Development Merton V. Smith, Ph.D., J.D. Director International Programs and Product Standards Center for Veterinary Medicine, FDA.

Slides:



Advertisements
Similar presentations
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Advertisements

Foundations of Regulation
Rule-Making Book II EU Administrative Procedures – The ReNEUAL Draft Model Rules 2014 Brussels, May th Herwig C.H. Hofmann University of Luxembourg.
ICH Q4B Regulatory Acceptance of Analytical Procedures and/or Acceptance Criteria (RAAPAC) Overview and Update Robert H. King, Sr. Office of Pharmaceutical.
SUCCESSFUL SUMMER STRATEGIES SPRING 2009 Federal and State Administrative Research.
FDA Research: Clearance Requirements and Implications Steven L. Bradbard, Ph.D. Team Leader, Consumer Studies CFSAN/ORPSS.
Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
Presented January 20, 2011 by: John Allen Director, Flight Standards Service (AFS-1) Federal Aviation Administration Public Aircraft Operations Forum.
Development of Guidance Documents Jennifer Scharpf, M. P. H
Administrative law research April 1, 2008 Melanie Dunshee.
Legislative Rule-Making Process. Three Different Processes Higher Education 29A-3A-1 et seq State Board of Education 29A-3B-1 et seq All other state agencies.
Introduction to Regulation
1 CFR CHAPTER I AND 1 CFR PART 51 REGULATORY UPDATE.
Administrative Law Research Ann Hemmens University of Washington Law Library Legal Analysis February 28, 2005.
Section 1 Guidelines for Office of Inspector General Quality Control and Assurance Programs Peer Review Training – National Science Foundation August 16,
Animal Feed GRAS Notifications Geoffrey K. Wong, M.S. Division of Animal Feeds Center for Veterinary Medicine Pet Food Institute Pet Food Institute October.
Powers and Functions of Administrative Agencies
Powers and Functions of Administrative Agencies. Question - Net-Neutrality FTC Announced Final Regulations – Late February 2015 Imagine you are a member.
William H. Foster Assistant Administrator, Headquarters Operations October 27, 2008 NABCA Administrators Conference Product Labeling and Packaging.
1 ACPS November 15, Update Nancy B. Sager, Associate Director Office of Pharmaceutical Science Center for Drug Evaluation & Research Food and.
Safeguarding Animal Health 1 Proposed BSE Comprehensive Rule: A New Approach to BSE Rulemaking Dr. Christopher Robinson Assistant Director, NCIE BSE Comprehensive.
Regulations and Administrative Law Research Refreshers Amy Taylor March 18, 2010.
PROPOSALS THE REVIEW OF THE 1958 AGREEMENT AND THE INTRODUCTION OF INTERNATIONAL WHOLE VEHICLE TYPE APPROVAL (IWVTA) IWVTA Informal Group WP th Session.
DRAFT Guidance for Industry: Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing Denise Sánchez, J.D.,
© 2004 West Legal Studies in Business A Division of Thomson Learning BUSINESS LAW Twomey Jennings 1 st Ed. Twomey & Jennings BUSINESS LAW Chapter 6 Administrative.
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
1 Updates to Texas Administrative Code 1TAC 206 Jeff Kline, Statewide Accessibility Coordinator Texas Department of Information Resources February 8, 2012.
Update on the Family Smoking Prevention and Tobacco Control Act Mike Freiberg & Joelle Lester National Association of Chronic Disease Directors General.
Regulations and Administrative Law. Roadmap What is Administrative Law? What is the rulemaking process? How do you find and update regulations? How do.
Agency Drafts Statement of Scope Governor Approves Statement of Scope (2) No Agency Drafts: Special Report for rules impacting housing
Secretary’s Advisory Committee on Human Subjects Protections (SACHRP) Summary of Responses on: Advanced Notice of Proposed Rulemaking (ANPRM) on Holding.
FDA’s Draft LDT Framework & Personalized Medicine Update
Summary of Rulemaking in California for the Forensic Alcohol Laboratories Regulation Review Committee Cathy L. Ruebusch, RN, MSN Office of Regulations.
1 FDA’s Framework for Reviewing Regulations Leslie Kux Acting Assistant Commissioner for Policy U.S. Food and Drug Administration March 10, 2011.
Legal Information on the Web - can we trust the official version? Jules Winterton Institute of Advanced Legal Studies, University of London International.
LAW OF COMPUTER TECHNOLOGY FALL 2015 © 2015 MICHAEL I. SHAMOS Regulatory Law Michael I. Shamos, Ph.D., J.D. Institute for Software Research School of.
Overview of FDA's Regulatory Framework for PET Drugs
PhRMA Perspective on FDA Final Report FDA Advisory Committee on Pharmaceutical Sciences October 20, 2004 G.P. Migliaccio, Pfizer Inc.
Welcome and Introduction Lee S. Simon, MD Division Director Analgesic, Anti-inflammatory and Ophthalmologic Drug Products ODEV/CDER.
OHRP Guidance and Policy Development Process Secretary’s Advisory Committee on Human Research Protections Meeting October 27, 2008 Irene Stith-Coleman,
Chapter 6: Administrative Agencies
Progress in FDA’s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003.
Enforcement Litigation and Compliance Washington, DC December 9-10, 2015 Compliance Central with FDA Center Compliance Directors (Part I) Michael Roosevelt,
Animal Drug Import Tolerances Under ADAA of 1996 FDA’s Public Health Protection, International Harmonization, and Trade-Related Goals Merton V. Smith,
WHAT THEY ARE, HOW THEY CHANGE MRAM MARCH 2014 OFFICE OF SPONSORED PROGRAMS GRANTS INFORMATION MEMORANDA.
Presented by Eliot Christian, USGS Accessibility, usability, and preservation of government information (Section 207 of the E-Government Act) April 28,
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
OCTGT Guidance Document Update Rachael Anatol, Ph.D. Associate Director for Policy-New Legislation February 26, 2014.
Federal Rulemaking Primer January 29, 2016 First Published: April 24, 2013 Producer: Alexander Perry Director: Afzal Bari.
Research Policy: ORD & ORO Working Together Brenda Cuccherini, PhD Office of Research & Development & Tom Puglisi, PhD Office of Research Oversight.
DEPARTMENT OF HEALTH CENTER FOR BIOLOGICS AND HUMAN SERVICESEVALUATION and RESEARCH AND HUMAN SERVICES EVALUATION and RESEARCH Update on OCTGT Guidance.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
Fostering Antimicrobial Stewardship in Animals: Overview of FDA Activities William Flynn, DVM, MS Deputy Director for Science Policy Center for Veterinary.
Session 3: How to use VICH GLs VICH5 Conference, October 2015, Tokyo 1.
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
Making Comments Count for High-Impact Regulations and Guidelines in the US Virginia (Ginny) Beakes-Read Executive Director, Global Regulatory Policy and.
The American Experience in Regulatory Review and Reform Dominic J. Mancini, PhD. Office of Information and Regulatory Affairs U.S. Office of Management.
McGraw-Hill/Irwin Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved.
Citizen’s Advisory Council Meeting September 19, 2017
Rulemaking Part II.
The Rulemaking Process
Information Technology Policy Institutional Data Policy
FDA 21 CFR Part 11 Overview June 10, 2006.
Follow the Rules: An overview of the rulemaking process and the Solid Waste Handling Standards Upate.
Chevron U.S.A., Inc. v. NRDC, 467 US 837 (1984) - 560
Chapter 6 Powers and Functions of Administrative Agencies.
What is OAL? The Office of Administrative Law (OAL) ensures that agency regulations are clear, necessary, legally valid, and available to the public. OAL.
Wyoming Administrative Procedure Act
FDA Regulation of Animal Biotechnology Products
Periodic Review and Expiration of Existing Rules (G.S. 150B-21.3A)
Presentation transcript:

Guidance Development Merton V. Smith, Ph.D., J.D. Director International Programs and Product Standards Center for Veterinary Medicine, FDA

FDA - Laws and Regulations Laws (Statutes) over 200 laws since 1906 that authorize and direct the regulatory activities of the FDA Rules (Regulations) –issued pursuant to statutory authority –implement statutes –have the force and effect of law –published in the FR and in the CFR

What are guidance documents? Guidance - a statement of policy on a regulatory issue or an interpretation of a statute or regulation Represents the agency’s current thinking on a regulatory issue VICH guidelines are classified as guidance in the U.S. Notices of availability are published in FR and guidances are available on CVM’s website

Guidance Documents Do not have the force and effect of law Not compulsory; an alternative approach can be used if the approach satisfies the requirements of applicable statutes and regulations Defendant can bring evidence into court that alternative approach meets statutory or regulatory requirements

Guidance Documents Guidance documents may relate to the: –design, production, labeling, promotion, manufacturing, and testing of regulated products –the processing, content, and evaluation or approval of submissions –inspection and enforcement policies

Guidance Development FDA is required to publish a guidance agenda listing upcoming guidance and a comprehensive list of Agency guidance periodically. CVM maintains a guidance agenda on its Internet site listing the guidances it intends to issue in the current year. This enables the public to see what the Center is working on.

Procedure for Developing Guidance Procedure is prescribed by regulation (“good guidance practices”) –Draft guidance is made available for public comment (typically 60-day comment period) –Draft guidance may be revised based on public comment –Final guidance is made available to public

Guidance Development Public can comment on guidance at any time – –Draft guidances have stated periods for public comment prior to finalizing the guidance, but the Docket remains open for future updates and revisions Guidance can be revised at any time –Advances in science or technology, new information, new policy –If VICH guidance is considered for revision, it would be brought to the VICH Steering Committee for consideration at Step 9 in the VICH review process

FDA and VICH Guidelines FDA delegates ensure that VICH guidelines do not contradict United States statutory or regulatory requirements VICH guidelines are revised to conform to FDA's good guidance practices regulation and published as Guidances